Dr Smith interviews Dr Danial Schecter from Cananda who heads up the Canadian Cannabinoid Medical Clinic (CMClinic) and is on an educational tour of Australia and New Zealand. In part II, we discuss cannabis and driving in NSW and the impact of THC on licencing, we also delve deeper into the differences between THC and CBD. We discuss how physicians can select the correct patient population for management of their patient's problems and make strong delineations between medicinal and recreational cannabis use.  

1) Lambert Initiatives study "Knowledge and attitudes of Australian general practitioners towards medicinal cannabis: cross-sectional study" ; https://bmjopen.bmj.com/content/8/7/e022101.full 2) COMPASS study - https://www.jpain.org/article/S1526-5900(15)00837-8/fulltext

The Praxhub educational modules designed for pharmacists and doctors. They are an independent educational group that delivers educational modules for HCPs. https://praxhub.com/medicinal-cannabis-registration/ 

For further information for patient group,  it is best to provide the information delivered by United in Compass. A patient advocacy group that is unbiased and provides information in lay language for the general public: https://unitedincompassion.com.au/resources-2/ 

3) For more information on using medicinal cannabis and driving, please read:   https://www.medicinalcannabis.nsw.gov.au/__data/assets/pdf_file/0025/2869/Cannabis-and-Driving-Fact-Sheet-Health-Professionals-FINAL.pdf 

See www.lejeunemedical.com.au

With thanks to Canopy Growth Corporation & Spectrum Therapeutics